Sharesify

Speakers analyze Nvidia's record Q3 earnings, Anthropic's IPO pricing, and updates on Convatec, Diploma, and Hays.

10 min Listen to the original Episode page
NvidiaAnthropic IPOApplied NutritionConvatecDiplomaHaysCeres PowerEarnings Guidance

Summary

Speaker 1 highlights Nvidia's Q3 results, noting a 103% revenue surge to $116 billion and raised Q4 guidance to $134 billion, alongside a 75% sales growth forecast for 2027. The discussion covers Anthropic's IPO, priced at the top of its range with pre-IPO quotes suggesting a potential pop, and Applied Nutrition, whose shares fell despite growth due to margin pressures. Convatec and Diploma are noted for raised guidance and beating forecasts, respectively, though valuation concerns limited Diploma's stock movement. Hays reported profits above consensus driven by German operations, while Ceres Power secured a major energy storage deal despite being heavily shorted.

Key takeaways

  1. 1
    It returned $28 billion just in Q three in dividends and buybacks. And the board Yeah, and the board I mean that's more. than most FTSE companies are worth. Uh, and get this the board expanded the buyback authorization to $150 billion.

    Unidentified speaker (speaker_1) · 1:05

Episode sections

  1. 0:24 – 2:12

    Nvidia Q3 Earnings and Guidance

    Speaker 1 discusses Nvidia's Q3 earnings, noting a 103% revenue surge to $116 billion, beating estimates. The company raised Q4 guidance to $134 billion and expanded its buyback authorization to $150 billion, with interim CEO Colette Crest raising the 2027 sales growth forecast to 75%.

  2. 2:12 – 3:48

    Anthropic IPO and Applied Nutrition

    The speakers cover Anthropic's IPO, priced at the top of the $70-$80 range with pre-IPO quotes around $96-$97. They also discuss Applied Nutrition, noting that shares fell despite strong growth due to a lack of guidance upgrade and margin pressure from US sales mix changes.

  3. 3:48 – 5:42

    Convatec, Diploma, and IQE Updates

    Convatec is highlighted as a FTSE 100 hidden gem with raised revenue guidance and accelerating growth. Diploma beat forecasts with above-consensus guidance for FY27 but saw limited share price movement due to high valuation. IQE may raise revenue guidance due to AI and data center opportunities.

  4. 5:42 – 7:59

    British Land, Hays, and Ceres Power

    British Land raised FY27 EPS guidance slightly. Hays reported first-half operating profit materially above consensus, driven by positive net fee income growth in Germany, prompting analyst upgrades. Ceres Power signed a major on-site energy storage deal despite being heavily shorted.

  5. 7:59 – 10:09

    Upcoming Earnings and Business Updates

    The speakers preview upcoming results for Walmart, JD Sports, Sage, Babcock, and Eagle Eye. They also mention a call with Traxis, a mobility software firm, and note that Home Depot, Lowe's, and Target recently delivered strong results.

Assets discussed

AssetKindStanceContext
NVIDIANVDAequitybullishSo in NVIDIA, the chipmaker, came out with Q three earnings last night. And uh there was it wasn't so much a concern that it would wouldn't meet or beat, but it it was the guidance and whether they would actually maintain or maybe even remove the guidance.

“Stance” is how the speakers talked about the asset, not a recommendation.

Claims worth verifying

Nvidia Q3 sales doubled to $116 billion, beating the $109 billion estimate.

Unidentified speaker (speaker_1) ·0:45

How to verify: Nvidia Q3 2026 Earnings Report via SEC EDGAR or Nvidia Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Nvidia Q3 net income doubled to $65 billion, beating the $60 billion estimate.

Unidentified speaker (speaker_1) ·0:45

How to verify: Nvidia Q3 2026 Earnings Report via SEC EDGAR or Nvidia Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Nvidia Q3 EPS was $2.70, beating the ~$2.50 forecast.

Unidentified speaker (speaker_1) ·0:45

How to verify: Nvidia Q3 2026 Earnings Report via SEC EDGAR or Nvidia Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Nvidia returned $28 billion in dividends and buybacks in Q3.

Unidentified speaker (speaker_1) ·1:05

How to verify: Nvidia Q3 2026 Earnings Report via SEC EDGAR or Nvidia Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Nvidia expanded buyback authorization to $150 billion.

Unidentified speaker (speaker_1) ·1:05

How to verify: Nvidia Q3 2026 Earnings Report via SEC EDGAR or Nvidia Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Nvidia Q4 sales guidance raised to $134 billion, beating the $125 billion estimate.

Unidentified speaker (UNKNOWN) ·1:23

How to verify: Nvidia Q3 2026 Earnings Report via SEC EDGAR or Nvidia Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Interim CEO Colette Crest raised 2027 sales growth forecast to 75%.

Unidentified speaker (speaker_1) ·1:43

How to verify: Nvidia Q3 2026 Earnings Report via SEC EDGAR or Nvidia Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Anthropic IPO priced at top of $70-$80 range.

Unidentified speaker (speaker_1) ·2:17

How to verify: Anthropic IPO Prospectus filed with SEC EDGAR. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Applied Nutrition shares fell due to lack of guidance upgrade and margin pressure from US sales mix.

Unidentified speaker (UNKNOWN) ·3:38

How to verify: Applied Nutrition Q3 2026 Results Announcement via LSE RNS. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Hays first-half profit well above market expectations due to positive net fee income growth in Germany.

Unidentified speaker (speaker_1) ·6:43

How to verify: Hays H1 2026 Interim Results Announcement via LSE RNS. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify Nvidia's Q3 earnings report and guidance details in the official SEC 8-K or investor presentation.
  • Check Anthropic's S-1 filing for the final IPO price and lock-up expiration dates.
  • Review Applied Nutrition's latest earnings call transcript for specific margin commentary and US sales mix data.
  • Examine Convatec's investor presentations for details on new product launches and market share gains.
  • Analyze Diploma's valuation multiples relative to peers to assess if the stock is overextended.
  • Research Hays' German operations performance and net fee income growth drivers.
  • Investigate Ceres Power's short interest levels and the terms of the on-site energy storage deal.
  • Check upcoming earnings calendars for JD Sports, Sage, Babcock, and Eagle Eye for expected guidance updates.
Full transcriptexpand

0:06Unidentified speaker (UNKNOWN): Hello

0:06Unidentified speaker (speaker_0): and welcome to our regular Wednesday podcast. Just me and Ian today. How's it going, Ian?

0:11Unidentified speaker (UNKNOWN): Hey,

0:11Unidentified speaker (speaker_1): not bad, James. Not bad. Lots going on.

0:13Unidentified speaker (UNKNOWN): Yeah,

0:14Unidentified speaker (speaker_0): absolutely. So global stock markets attempt to break this multi-day tech sell-off, but things have calmed down a bit after recent volatility. And a lot of that's to do with some good news from one of the world's biggest companies, isn't

0:24Unidentified speaker (UNKNOWN): it?

0:24Unidentified speaker (speaker_1): It is, James, yeah. So in NVIDIA, the chipmaker, came out with Q three earnings last night. And uh there was it wasn't so much a concern that it would wouldn't meet or beat, but it it was the guidance and whether they would actually maintain or maybe even remove the guidance. Um and as it happened, earnings were fine. Um it beat forecast, it raised guidance. Uh sales doubled to one $116 hundred and sixteen billion dollars. The estimate was $109 billion. Net income again pretty much doubled to $65 billion. The estimate was $60 billion. And earnings per share were $2.70. And the forecast was about two and a half bucks. So uh it also returned this is ridiculous numbers. It returned $28 billion just in Q three in dividends and buybacks. And the board Yeah, and the board I mean that's more. than most FTSE companies are worth. Uh, and get this the board expanded the buyback authorization to $150 billion.

1:23Unidentified speaker (UNKNOWN): Wow.

1:23Unidentified speaker (speaker_1): Um, yeah, madness. Uh so guidance. The Q4 sales are now seen around $134 billion. The estimate was $125. And I think you've got to bear in mind with these guys, you know, that they are sold out for the next year or so. So I think it was always going to be in the bag. In fact, interestingly, the interim CEO Colette Crest uh raised because Jensen Wong said in September sales in 2027 would grow 70%. She upped that to 75%, and her her little phrase at the end was, We've got this. So shares went up after Mark. aftermarket, and in five of the last eight quarters, they've gone down after market because the guidance disappointed. So yeah, you know, markets seem pretty relaxed now.

2:12Unidentified speaker (speaker_0): Right. And there's also some good news on the uh anthropic IPO, I believe.

2:17Unidentified speaker (speaker_1): Yeah, uh apparently the company's looking to price it at the top of the IPO range, which is between seventy $70 and eighty $80. dollars. And looking a little earlier on Bloomberg, there's a platform called Hyper Liquid, which I've never heard of before. Um, it makes kind of quotes, pre IPO quotes, and they're looking at something like $96 97 is the forecast now. So that's something like a 20% pop. Um, for anybody who hasn't been following the story, Anthropic is the maker of the Clawed chatbot, and this is generally regarded, I think, as having the best growth runway of all the current models out there. You can still apply if you're a UK investor, it is likely to be oversubscribed, so you will be scaled back. But it's the world's biggest IPO. Uh I and I I've put in for some. Have you put in for any James?

3:07Unidentified speaker (speaker_0): I haven't yet, no.

3:09Unidentified speaker (UNKNOWN): No,

3:09Unidentified speaker (speaker_1): I tend not to go for these tech IPOs, IPAs, but I thought that look it's the world's biggest. As I say, it's supposed to have. the best growth runway. We'll see how it goes. But talking of uh new issues, you were very much looking at applied nutrition, which came to market not that long ago.

3:23Unidentified speaker (speaker_0): Yeah, that's right. And it and it sort of harks back to that the importance of guidance point, I think, Ian. So applied nutrition is an outstanding year of growth, growing broad based across geographies and channels, but they stopped short of another upgrade, and I think that disappointed investors. Um there was also they reiterated

3:38Unidentified speaker (UNKNOWN): some

3:38Unidentified speaker (speaker_0): sort of margin pressure from a bit of a change in the sales mix more to the US and some highway prices. So I think that was uh what what caused the shares to fall on the day.

3:48Unidentified speaker (UNKNOWN): And then

3:48Unidentified speaker (speaker_0): um yeah and another one that caught my was Imperial brands. Now here a six consecutive year of growth in tobacco and next generation products which is is quite surprising given the kind of headwinds in that sector. Um, Plus

3:59Unidentified speaker (UNKNOWN): a big

4:00Unidentified speaker (speaker_0): cost savings target. But again here it was a more pronounced second half waiting, which uh kind of spooked investors. That means they've got a lot to do in the the second half to meet their numbers. But um, on a brighter note, have you heard of ConvoTech? Now, this is a bit of a hidden gem within the FTSE 100, so it's medical devices and solutions to help manage chronic conditions, and that company actually raised revenue guidance, so growth has accelerated in the second half, and I think there could be more upgrades on this one because it's uh it's rolling out a lot of new product launches and taking market share. So that's that's the one that's caught my eye.

4:31Unidentified speaker (speaker_1): Yeah, it's part owned, I believe, by the Danish firm Koloplast, which has always been if you if you you know look at European quality growth companies, any investor that buys quality growth European companies, coloplast Plast was always a fixture, I seem to recall.

4:48Unidentified speaker (UNKNOWN): Right.

4:48Unidentified speaker (speaker_1): Yeah, interesting. interest And talking of quality growth, we have had diploma results uh this week as well. Now, it is the archetypal quality growth, along with Halmer, archetypal quality growth, beat forecasts and uh issued guidance that was above the consensus for FY27.

5:06Unidentified speaker (UNKNOWN): But

5:06Unidentified speaker (speaker_1): the shares they didn't really make much headway. And I think the problem is there that it's just valuation. They've had a terrific run in the last couple of years. It's a sort of we've always said, you know, dull is good. And it is dull, but it's a heck of a compounder. And investors love it. But it's just got to a level where I think it's going to straggle price-wise. Same thing happened with Helma uh earlier this year. But uh we did have some more beats and raises. So um IQE, which makes uh compound semiconductors, they might raise their revenue guidance because they're seeing more opportunities in AI and data centers. Today we have British Land raise its earnings per share guidance for fully only a tiny amount from 30 and a halfp to 31p. But we know because we were at the presentation with Alan Lockhart of New River Reed, who was saying that this is just a fantastic time for the retail property sector, and British land is big in retail, it's big in office campuses, and it's big in uh urban logistics as well. So they've raised guidance, and interesting, you mentioned second-half uh weightings because Hayes, which has had the odd fog start, but has had quite a

6:23decent run since sort of mid-year. Uh Hayes came out as and you know, we looked at these before and said, Oh, is it time to buy them? The net fee income growth is finally, we've gone from you know, bad, bad, bad to not so bad to now actually quite actually better. And Hayes said that first half profit will be well above market expectations because that net fee income growth has turned positive, particularly in Germany. And they said. second half, it's usually second half weighted. So they don't see and they don't see that changing. So in other words, not only is the first half going to be above expectations, assuming that momentum carries on into the second half, then the second half is going to be so analysts are scrambling to upgrade. I think at one point I looked at it was up 20%.

7:09Unidentified speaker (UNKNOWN): Oh

7:09Unidentified speaker (speaker_0): wow, okay.

7:10Unidentified speaker (speaker_1): Pretty impressive. Um and the other one I'd flag is Ceres Power. which has signed a major deal for its um on-site energy storage uh thing. Now this is interesting because it's the most shorted stock in the UK. Something like 18-19% of the shares are on you know on loan. The reason is because it had an absolutely gangbusters first half of the year. The stock basically 10 bagged in the space of about four months. Um and then and that's just drifted off. And when I say drift off, it's drifted off 50%. That's still up five times since the start of the year. Uh, this is actually one that Laura, Laura Fole, said in her presentation she'd taken some money off the table in this in the summer, so she would have got a nice price for it.

7:57Unidentified speaker (speaker_0): Yeah, absolutely.

7:58Unidentified speaker (UNKNOWN): Um,

7:59Unidentified speaker (speaker_1): what are we looking forward to then, James? What have we still got to come this week?

8:02Unidentified speaker (UNKNOWN): Well.

8:03Unidentified speaker (speaker_0): it's a big week for US resale. Actually, the the reports so far have been quite resilient. So we had um Home Depot and Lowe's both delivered beats. That's despite our more abundant housing market across the pond. Target's just delivered its best sales growth in five years and raised guidance. That's a bit of a turnaround story under um a sort of Lifer who who's we're We turning the recovery around there. And then later today we've got TJX, and then the big one is tomorrow. where we've got third quarter earnings from Walmart, which is the world's biggest retailer. Um, what have we got tomorrow? We've got JD Sports, also has a big US presence, and uh, you know, interesting there to see what they say about newness

8:38Unidentified speaker (UNKNOWN): in the

8:38Unidentified speaker (speaker_0): sneaker category, how the you know the younger demographic holding up, and we've also got Weatherspoons AGM tomorrow. So always interesting uh stuff. What about you, Ian? What have you got your eye aisle? on?

8:49Unidentified speaker (speaker_1): Um, well, I mentioned how. Helmer. Helmer's out tomorrow. Uh sorry, out tomorrow Friday. Um Sage, another quality growth name, that's a Nick Train name, if I'm not mistaken. Um

9:00Unidentified speaker (UNKNOWN): then

9:00Unidentified speaker (speaker_1): we've got Babcock in the defence sector, Eagle Eye, which is a small one, but I quite like, and hands up, I'm an owner. This business uh is set up by the guy who who did the club card for Tesco, and it b basically does the in-person, the personalized marketing for big supermarket trains. It's very big in the US. So very interesting to see how that one goes. And then I've got a call with a firm I've never spoken to before called Traxis, which is quite interesting. It does um mobility software, so it tracks vehicles for fleet owners, and even down to small firms. like plumbers and builders who need to know where the vans are and yeah what's going on with them. So

9:44Unidentified speaker (speaker_0): yeah,

9:45Unidentified speaker (speaker_1): you know, we'll see how that one goes. Excellent.

9:49Unidentified speaker (speaker_0): Yeah.

9:49Unidentified speaker (UNKNOWN): Well

9:50Unidentified speaker (speaker_1): that's it, I think, for us. Um so guys, if you uh want to tune in on Friday, uh we'll see you then. And for now, it's uh buy bye from us.

10:01Unidentified speaker (speaker_0): See you later.

This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.
All insights